Drug Shortage Report for TOBI
| Report ID | 192953 |
| Drug Identification Number | 02239630 |
| Brand name | TOBI |
| Common or Proper name | TOBRAMYCIN |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | TOBRAMYCIN |
| Strength(s) | 300MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INHALATION INHALATION |
| Packaging size | 56 AMPULES |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-06-01 |
| Actual start date | 2023-05-31 |
| Estimated end date | 2024-10-01 |
| Actual end date | 2024-05-31 |
| Shortage status | Resolved |
| Updated date | 2024-10-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v57 | 2024-10-04 | French | Compare |
| v56 | 2024-10-04 | English | Compare |
| v55 | 2024-09-24 | French | Compare |
| v54 | 2024-09-24 | English | Compare |
| v53 | 2024-09-03 | French | Compare |
| v52 | 2024-09-03 | English | Compare |
| v51 | 2024-08-12 | French | Compare |
| v50 | 2024-08-12 | English | Compare |
| v49 | 2024-08-06 | French | Compare |
| v48 | 2024-08-06 | English | Compare |
| v47 | 2024-07-29 | French | Compare |
| v46 | 2024-07-29 | English | Compare |
| v45 | 2024-07-23 | French | Compare |
| v44 | 2024-07-23 | English | Compare |
| v43 | 2024-07-03 | French | Compare |
| v42 | 2024-07-03 | English | Compare |
| v41 | 2024-06-25 | French | Compare |
| v40 | 2024-06-25 | English | Compare |
| v39 | 2024-05-17 | French | Compare |
| v38 | 2024-05-17 | English | Compare |